Abstract
Analyzing data from a large, nationally distributed group of Japanese hospitals, we found a dramatic decline in both inpatient and outpatient volumes over the three waves of the COVID- 19 pandemic in Japan from February-December 2020. We identified three key reasons for this fall in patient demand. First, COVID-19-related hygiene measures and behavioral changes significantly reduced non-COVID-19 infectious diseases. Second, consultations relating to chronic diseases fell sharply. Third, certain medical investigations and interventions were postponed or cancelled. Despite the drop in hospital attendances and admissions, COVID-19 is said to have brought the Japanese health care system to the brink of collapse. In this context, we explore longstanding systematic issues, finding that Japan’s abundant supply of beds and current payment system may have introduced a perverse incentive to overprovide services, creating a mismatch between patient needs and the supply of health care resources. Poor coordination among health care providers and the highly decentralized governance of the health care system have also contributed to the crisis. In order to ensure the long-term sustainability of the Japanese health care system beyond COVID-19, it is essential to promote specialization and differentiation of medical functions among hospitals, to strengthen governance, and to introduce appropriate payment reform.
Highlights
Highlights
▪ Patient volumes in Japanese hospitals fell sharply due to the COVID-19 pandemic.
▪ Behavioral changes and appointment cancellations contributed to the decline.
▪ Japan’s health system reached breaking point due to longstanding systematic issues.
▪ There is a mismatch between patient needs and the supply of health care resources.
▪ Payment reform and stronger governance are needed to future-proof the health system.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by Grants-in-Aid for Scientific Research (25285090, PI:Masako Ii) and HIAS (Hitotsubashi Institute for Advanced Study).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was given ethics approval by the Hitotsubashi University Research Ethics Screening Committee (ID: 2021C017). Committee chair: SAIKI Yoshitaka (Graduate School of Business Administration, Department of Business Administration) Committee members: OKADA Erica (Graduate School of Business Administration, Department of Business Administration), TOMOBE Kenichi (Graduate School of Economics), MIZUMOTO Hironori (Graduate School of Law), IKAI Shuhei (Graduate School of Social Science), KOSEKI Takeshi (Graduate School of Language and Society), TESHIMA Kensuke (Institute of Economic Research, Research Division of Comparative and World Economics)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: swatanabe{at}ghc-j.com
Data Availability
The data used in this study is clinical data that hospitals disclose to the Japanese Ministry of Health, Labour and Welfare when claiming DPC payments for medical services. In order to improve hospital management and standards of care, some hospitals also choose to send the data to external companies and organizations for benchmarking. In this case, the data is fully anonymized and any personal information encrypted or deleted before analysis. However, the hospitals themselves are the ultimate owners of the data, and due to its inherent personal and sensitive nature, do not make it available for public access.
